VolitionRx Limited Celebrates CE Mark Announcement By Ringing Closing Bell at the New York Stock Exchange

USA - English

• USA - English

The event was preceded earlier that day by a more traditional bell ringing ceremony at Trinity Church Wall Street led by Volition's Chairman, Dr. Martin Faulkes. Dr. Faulkes, a keen bell ringer, donated and installed the 12 bells at Trinity Church Wall Street in 2006.

Speaking about the celebration, Cameron Reynolds, CEO of Volition said: "We are very pleased to be at the NYSE at this very exciting time for Volition. We are coming to market with a diagnostic cancer test that we believe meets a pressing and immediate need in many European countries. Being able to offer healthcare systems a simple and easy to use blood test, which may be used to triage FIT positive populations for colorectal cancer, has the potential to make a significant and positive difference for their national colorectal cancer screening programs."

An archive of the video for the New York Stock Exchange closing bell ceremony with Volition may be accessed at www.nyse.com/bell.

Contact:

Scott Powell, Ph.D.
Executive Vice President
VolitionRx Ltd. (NYSE MKT: VNRX)
Office: +1 646-650-1351
Cell: +1 917-721-9480
Email: [email protected]

Louise Day
Chief Marketing and Communications Officer VolitionRx
Mobile: +44 (0) 7557774620  
Skype: annloday11
[email protected] 

SOURCE VolitionRx Limited